Babek Tabandeh
- 4.4 Жақсы • 30 пікірлер
- аккредитациялар:
- Түркия, Істанбұл, Medical Park Göztepe Hospital Complex
Associate Professor of General and Bariatric Surgery. Specializes in laparoscopic (minimally invasive) surgery.
Associate Professor of General and Bariatric Surgery. Specializes in laparoscopic (minimally invasive) surgery.
Specialist in endoscopic surgery
Oncosurgeon
Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.
Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).
Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
Deputy Head of the Department of Oncology. One of the leading Israeli specialists in the digestive tract tumors, sarcoma and melanoma
Professor Michele Reni is an experienced medical oncologist with over 30 years of practice based in Italy. He specializes in pancreatic adenocarcinoma, gastro-esophageal cancers, and central nervous system tumors. He has published over 180 papers on cancer treatment and is the coordinator of Italian Association of Medical Oncology (AIOM) guidelines for treatment and management of pancreatic cancer. He has also chaired numerous clinical trials on treating patients with metastatic pancreatic cancer.
Dr. Konstantin Kopchak is a Senior Researcher at the National Institute of Surgery and Transplantology. He also works as a Leading Research Fellow at the National Cancer Institute. His main focus is surgical treatment and diagnostics, especially for pancreatic cystic diseases.
Dr. Kopchak has defended his thesis and written over 170 scientific papers, including 2 monographs. He has 30 publications indexed in Scopus (h-index: 2), showing his strong contribution to medical research.
Dr. Alexander Beny is a Oncologist at the Rambam Medical Center who is Board Certified in Oncology and speaks English and Hebrew. He has extensive experience and education in the field and is available for contact at the hospital.